Compass Therapeutics, Inc. Income Statement

Income Statement Mar2019 Dec2019 Mar2020 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.00M-1.23M-0.01M-0.91M-0.37M0.85M
Gross Profit -0.00M-1.23M-0.01M-0.91M-0.37M0.85M
Operating items
Research & Development 22.45M14.90M20.34M30.00M38.12M42.34M
Selling, General & Administrative 0.03M11.60M0.03M12.91M10.93M11.66M12.24M15.13M
Other Operating Expenses 50.62M
Operating Expenses 0.03M34.05M0.03M27.81M81.88M41.66M50.36M57.48M
Operating Income -0.03M-34.05M-0.03M-27.81M-81.88M-41.66M-50.36M-56.62M
EBIT -0.03M-34.05M-0.03M-27.81M-81.88M-41.66M-50.36M-56.62M
Non-operating items
Interest & Investment Income 0.74M0.09M0.03M2.36M7.87M
Other Non Operating Income 0.63M-1.66M-0.30M2.43M7.87M7.25M
Non Operating Income 0.63M-1.66M-0.30M2.43M7.87M7.25M
Net income details
EBT -0.04M-34.65M-0.04M-29.47M-82.18M-39.23M-42.49M-56.62M
Tax Provisions 0.09M0.03M
Profit After Tax -0.04M-34.74M-0.04M-29.50M-82.18M-39.23M-42.49M-49.38M
Income from Continuing Operations -0.04M-34.74M-0.04M-29.50M-82.18M-39.23M-42.49M-56.62M
Consolidated Net Income -0.04M-34.74M-0.04M-29.50M-82.18M-39.23M-42.49M-56.62M
Income towards Parent Company -0.04M-34.74M-0.04M-29.50M-82.18M-39.23M-42.49M-56.62M
Net Income towards Common Stockholders -0.04M-34.74M-0.04M-29.50M-82.18M-39.23M-42.49M-56.62M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 5.00M52.12M98.03M126.19M127.49M137.59M
EBITDA -0.03M-34.05M-0.03M-27.81M-82.18M-39.53M-42.16M-49.20M